日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world patient characteristics and utilization patterns in patients with cholangiocarcinoma who received pemigatinib in the United States of America

美国接受培米替尼治疗的胆管癌患者的真实世界患者特征和使用模式

Joshi, Spruha; Jing, Mengni; Wheeler-Martin, Katherine; Shah, Pooja; Davis, Corey S; DiMaggio, Charles J; Cerdá, Magdalena; Aoki, Tomoko; Tsurusaki, Masakatsu; Nishida, Naoshi; Morita, Masahiro; Chishina, Hirokazu; Takita, Masahiro; Hagiwara, Satoru; Minami, Yasunori; Ueshima, Kazuomi; Kudo, Masatoshi; Verma, S; Hughes, A; Engel-Nitz, NM; Steiger, C; Rodriguez, M; Blecker, M

Real-world patient characteristics and utilization patterns in patients with cholangiocarcinoma who received pemigatinib in the United States of America

美国接受培米替尼治疗的胆管癌患者的真实世界患者特征和使用模式

Wang, Junwei; Lv, Mei; Wang, Siyao; Verma, S; Hughes, A; Engel-Nitz, NM; Steiger, C; Rodriguez, M; Blecker, M

Real-world patient characteristics and utilization patterns in patients with cholangiocarcinoma who received pemigatinib in the United States of America

美国接受培米替尼治疗的胆管癌患者的真实世界患者特征和使用模式

Dionisi, Francesco; Mascari, Giulia; Sperduti, Isabella; Goanta, Lucia; Nardangeli, Alessia; Ordonez, Pedro; D'Andrea, Marco; Soriani, Antonella; Sanguineti, Giuseppe; Liu, Yi; Xiang, Ling; Cheng, Rui-Juan; Pan, Shu-Yue; Verma, S; Hughes, A; Engel-Nitz, NM; Steiger, C; Rodriguez, M; Blecker, M

Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary

接受培米替尼治疗的胆管癌患者(无论既往是否有原发性不明癌症病史)的经济和临床结局

Verma, Sumit; Hughes, Alejandro; Engel-Nitz, Nicole M; Steiger, Christina; Parasuraman, Shreekant; Javle, Milind; Lee, Sunyoung S; Saj, Fen; Blecker, Michael

Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort Study

多灶性运动神经病患者的特征、治疗模式、医疗资源利用和费用:一项基于美国医疗保险索赔数据库的队列研究

Khandelwal, Nikhil; Sanchirico, Marie; Ajibade, Ade; Munshi, Kiraat; Vu, Michelle; Engel-Nitz, Nicole; Steiger, Christina; Anderson, Amy J; Karam, Chafic

Identifying Potential Gaps in Care for Patients with Higher-Risk Myelodysplastic Syndromes in a Large US Health System

识别美国大型医疗系统中高危骨髓增生异常综合征患者护理方面的潜在差距

Moore, Kristin J; Engel-Nitz, Nicole M; McMahon, Peter; Beal, Jason; Jhaveri, Teraneh Z; Williamson, Mellissa; Andrade, Kate; Steiger, Christina; Hogea, Cosmina

Impact of Intravenous Iron Replacement Therapy on Healthcare Costs for Patients with Iron Deficiency Anemia in the USA: A Retrospective Analysis

美国静脉补铁疗法对缺铁性贫血患者医疗保健成本的影响:一项回顾性分析

Engel-Nitz, Nicole M; Kwong, Winghan Jacqueline; Wang, Kevin; Tran, Summer; Anderson, Amy

Complications, Costs, and Health Care Resource Use with Tissue Biopsy Followed by Liquid Biopsy Versus Tissue Re-biopsy in Patients With Newly Diagnosed Metastatic Nonsmall-cell Lung Cancer

对于新诊断的转移性非小细胞肺癌患者,组织活检后进行液体活检与再次进行组织活检相比,其并发症、成本和医疗资源利用情况的比较

Shah, Anne; Apple, Jon; Aslam, Saad; Engel-Nitz, Nicole M; Le, Lisa; Terpenning, Marilou

Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015-2018

2015-2018年美国普通风险健康计划参保者结直肠癌筛查相关的患者和医疗服务提供者因素

Engel-Nitz, Nicole M; Miller-Wilson, Lesley-Ann; Le, Lisa; Limburg, Paul; Fisher, Deborah A

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States

美国乙型肝炎感染但未患肝硬化的参保患者中肝细胞癌监测的不足

Nguyen, Mindie H; Roberts, Lewis R; Engel-Nitz, Nicole M; Bancroft, Tim; Ozbay, A Burak; Singal, Amit G